Literature DB >> 567016

Significance of lymph node metastasis in differentiated thyroid cancer.

J Harwood, O H Clark, J E Dunphy.   

Abstract

In age-matched patients with differentiated carcinoma of the thyroid, the tumor recurred in 32 per cent of those with lymph node metastases and in 14 per cent of those without lymph node metastases. Twenty-four per cent of patients with nodal involvement at the initial examination died of thyroid cancer, whereas only 8 per cent of those without nodal involvement died of thyroid cancer. In patients less than forty years old, there were no deaths in those without nodal metastases bu there were three deaths (11 per cent) in patients with nodal metastases. In patients more than forty years old, nine (41 per cent) iwth nodal metastases died of tumor, and four (15 per cent) without nodal metastases died of tumor. In the presence of positive nodes the death rate was substantially greater in the older than in the younger patients. Nodal involvement has an adverse effect on prognosis, but appears to be less important than the age of the patient.

Entities:  

Mesh:

Year:  1978        PMID: 567016     DOI: 10.1016/0002-9610(78)90209-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  30 in total

Review 1.  Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection.

Authors:  Robin M Cisco; Wen T Shen; Jessica E Gosnell
Journal:  Curr Treat Options Oncol       Date:  2012-03

Review 2.  Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 3.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

4.  Pathologic features of metastatic lymph nodes identified from prophylactic central neck dissection in patients with papillary thyroid carcinoma.

Authors:  Hyoung Shin Lee; Chanwoo Park; Sung Won Kim; Woong Jae Noh; Soo Jin Lim; Bong Kwon Chun; Beom Su Kim; Jong Chul Hong; Kang Dae Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-12       Impact factor: 2.503

Review 5.  Nodal metastases in thyroid cancer: prognostic implications and management.

Authors:  Laura Y Wang; Ian Ganly
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

6.  Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid.

Authors:  O Ozaki; K Ito; K Kobayashi; A Suzuki; Y Manabe
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

7.  Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma.

Authors:  Katsuhiro Tanaka; Hiroshi Sonoo; Mai Hirono; Sumiko Ohkubo; Tsunehisa Nomura; Masahiko Ikeda; Kazukata Nakajima; Junichi Kurebayashi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

8.  Is thymectomy worthwhile in central lymph node dissection for differentiated thyroid cancer?

Authors:  Ziad El Khatib; Julie Lamblin; Sebastien Aubert; Laurent Arnalsteen; Emmanuelle Leteurtre; Robert Caiazzo; Francois Pattou; Bruno Carnaille
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

9.  Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.

Authors:  Alexander Gorshtein; Carlos Benbassat; Eyal Robenshtok; Ilan Shimon; Dania Hirsch
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

Review 10.  RAS mutations in thyroid cancer.

Authors:  Gina M Howell; Steven P Hodak; Linwah Yip
Journal:  Oncologist       Date:  2013-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.